Therefore, in the present study, using a segmental osteoperiosteal bone defect (0.8 cm, in the middle of the left radius) that remained incompletely healed in all control rabbits for 6 weeks (assessed in 2-week intervals), pentadecapeptide BPC-157 was further studied (either percutaneously given locally [10 g/kg body weight] into the bone defect, or applied intramuscularly [intermittently, at postoperative days 7, 9, 14, and 16 at 10 g/kg body weight] or continuously [once per day, postoperative days 721 at 10 g or 10 ng/kg body weight])
Think of this as your "starter concentration," similar to how researchers reconstitute semaglutide at 5mg/mL for granular low-dose control
Both samples were incubated for 10 min at 85 C to inactivate the phosphatase, and then purified on C18 StageTips 33
They are sold strictly for research and laboratory testing
Heres when caution is advised: Allergy concerns: People allergic to cobalt or B12 should avoid injections
Because each vials beyond-use window is finite, plan to open the second vial only when you reach it rather than reconstituting both up front
